Target intelligence / Profile preview

Microbial 1,4-dioxane metabolic enzymes (SDIMO)

Target
SDIMO
Molecular classification
Enzyme, Monooxygenase, Soluble di-iron monooxygenase (SDIMO)
01

Overview

Microbial metabolic enzymes for 1,4-dioxane are a specialized group of bacterial oxygenases, predominantly belonging to the soluble di-iron monooxygenase (SDIMO) family, that catalyze the degradation of the environmental pollutant 1,4-dioxane [1, 7]. These enzymes, such as tetrahydrofuran monooxygenase (THF MO) and propane monooxygenase (PrMO), are responsible for the initial hydroxylation of the dioxane ring, a critical step that enables subsequent ring cleavage and mineralization [4, 5]. They are found in various bacterial genera, including Pseudonocardia, Mycobacterium, and Rhodococcus, and can operate through either direct metabolism or cometabolism with substrates like tetrahydrofuran or propane [8, 10]. Although not therapeutic targets in the context of human medicine, these enzymes are essential for bioremediation strategies aimed at removing 1,4-dioxane, a probable human carcinogen, from contaminated groundwater and industrial wastewater [6, 11]. Researchers use the genes encoding these enzymes, such as dxmA and thmA, as molecular biomarkers to assess the potential for natural attenuation or to monitor the progress of bioaugmentation in the field [7, 13]. The activity of these monooxygenases is susceptible to inhibition by substances like acetylene and certain chlorinated solvents, which can pose challenges for effective bioremediation in complex environmental matrices [9, 11].

Other names
1,4-Dioxane monooxygenaseTetrahydrofuran monooxygenaseTHF monooxygenasePropane monooxygenaseSoluble di-iron monooxygenaseSDIMODioxane monooxygenase (DXMO)
02

Mechanism of action

Hydroxylation of the alpha-carbon (C2) of the 1,4-dioxane ring to form 2-hydroxy-1,4-dioxane, followed by ring opening and further oxidation to 2-hydroxyethoxyacetic acid (HEAA) and eventually glyoxylate or carbon dioxide.

03

Biological functions

Xenobiotic metabolismBiodegradationOxidation of cyclic ethersCometabolism
04

Disease associations

Cancer
05

Safety considerations

Accumulation of toxic intermediates (e.g., 2-hydroxyethoxyacetic acid/HEAA)Inhibition by co-occurring chlorinated solventsRequirement for molecular oxygen and co-substrates
06

Interacting drugs

Acetylene (inhibitor)

2 more in the full profile.

07

Biomarkers

thmA genedxmA geneprmA geneSoluble di-iron monooxygenase (SDIMO) gene abundance

Beyond the preview

Go deeper on Microbial 1,4-dioxane metabolic enzymes (SDIMO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial 1,4-dioxane metabolic enzymes (SDIMO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call